Skip to main content

Posts

Your Skin Has Its Own Blueprint — Ultherapy PRIME and the Age of Hyper-Personal Lifting

 In non-surgical lifting, one question comes up again and again: why do results differ so much from person to person, even with the same treatment? The answer lies in individual anatomy — skin thickness, the depth of the lifting layer, and fat distribution all vary from person to person. Even with identical equipment and the same number of shots, results depend on whether the energy reaches the right layer beneath the skin. Ultherapy PRIME addresses exactly this — reading each patient's skin structure in real time with ultrasound and designing a treatment accordingly. As interest grows in this hyper-personalized approach to lifting, we sat down with Dr. Youngmin Cho of Cheongdam ANZ Dermatology Clinic. From pre-treatment facial mapping and transducer selection based on skin depth, to shot distribution tailored to each patient's primary concern, how discomfort is managed, differences in approach between male and female patients, and what first-timers should look for when choosin...
Recent posts

Safety, Natural Results, and Versatility Take Center Stage — Reading the 2026 Medical Aesthetics Market at the 28th Spring Meeting of the Association of Korean Dermatologists

 We were on site at the 28th Spring Meeting of the Association of Korean Dermatologists. Held on March 29 at the Swiss Grand Hotel in Seoul, the conference brought together dermatology specialists from across Korea for a practice-ready program featuring CME-accredited sessions, high-definition procedural video sessions, and lectures on complication prevention. This year also saw the launch of the inaugural Practice Management Exhibition, bridging clinical education and practice operations. Safety took center stage throughout the academic sessions — from the anatomical basis of botulinum toxin injection in facial muscles to post-filler ophthalmic complications and biostimulator nodule prevention. We also toured the exhibition floor. Across both medical aesthetic devices and injectables, "combination" and "safety" were the defining themes. Multi-wavelength and dual-frequency platforms are gaining ground beyond single-modality treatments, while differences in safety pr...

[Top Rankers] 2025 SUNNY Top Ranker — Dr. Gwahn Woo Cheon, Maylin Clinic Pangyo: 'A Device That Delivers Both Efficacy and Cost-Effectiveness'

 In the field of aesthetic medicine, high device usage is more than a number — it reflects accumulated clinical expertise and patient trust. The Top Rankers series spotlights physicians who have achieved consistently high real-world usage in their own practices. This installment features Dr. Gwahn Woo Cheon of Maylin Clinic Pangyo, named Top Ranker for SHENB's combined monopolar-bipolar RF platform, Sunny. Having worked extensively with major monopolar RF devices, he chose Sunny as his primary platform for its ADRT technology — expanding indications from lifting to melasma and pigmentation — and the Quasar tip's ability to conform to curved anatomy and the scalp. Describing Sunny as "a device that delivers both efficacy and cost-effectiveness," Dr. Cheon shares his full-face 1,200-shot 'Double Sunny' protocol, his Soft mode level 2.5 'golden parameter,' and insights from a melasma clinical study with Professor Kyunghee Byun's team.  #MedicalAesthet...

[KIMES 2026 Special ②] Delivery, Combination, and Formulation: The Growth Engines Beyond EBD

 KIMES 2026 Special, Part 2. Following Part 1 on the evolution of energy-based devices, we covered the new growth engines emerging beyond EBD. Clinical interest is no longer confined to energy-based devices alone. How drugs reach the dermis, how energy and drugs are combined in a single procedure, and how the range of available formulations is expanding — delivery, combination, and formulation are increasingly shaping the competitiveness of the overall treatment strategy. Needle-free injectors and needle-based delivery platforms are changing how drugs reach the dermis. A hybrid injector combining drug injection and RF in one device has emerged. And companies are expanding their formulation portfolios beyond exosomes to include biostimulators and HA fillers for the combination-treatment era. We visited four companies — BAZ BIOMEDIC, Curiosis, Huons Meditech, and Primoris International — on the exhibition floor to document this shift firsthand.  #MedicalAestheticNews #KIMES2026 ...

The Reference Injector in Medical Aesthetics Raises the Bar with DermaShine Duo RF

 The skin booster market is evolving beyond simple drug delivery toward multi-modality treatments. As patients and clinicians increasingly look beyond a single-modality approach, there is growing interest in integrated injectors that combine drug infusion and radiofrequency stimulation in one platform. The Dermashine Duo_RF is a next-generation hybrid injector designed to meet this demand, accelerating the collagen response and improving delivery efficiency. We sat down with Dr. Jonghoon Lee of Lyzbelle Clinic, who has used the Dermashine series — the established reference in injector technology — since 2015, to discuss synergies with polymers, PRP, and exosomes, reduction in treatment sessions, real-world RF parameter settings, and combination treatment strategies. #MedicalAestheticNews #HuonsMeditech #Dermashine #Dermashine_Duo_RFShineDuoRF #LyzbelleClinic #DrJonghoonLee ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11006

The Final Piece in the Combination Treatment Puzzle: SCULPIO — How Dr. Jaehong Kim Keeps 'Skincare Nomads' Coming Back

 With HIFU and RF firmly established as the two pillars of the lifting and tightening market, a picosecond laser-based approach known as PicoSculpting is emerging as a third option. LASEROPTEK's SCULPIO is a next-generation platform equipped with dedicated PS handpieces for PicoSculpting, adding facial contouring and skin tightening to the conventional pigment and toning repertoire. At the LEAD Symposium in January, Dr. Jaehong Kim of Yonsei Joeun Dermatology Clinic (Gwangmyeong) presented "The Start of 2026: My Choice Is SCULPIO." We sat down with Dr. Kim to discuss what led him to adopt SCULPIO, his combination treatment strategy, how he addresses the fine details that HIFU and RF leave behind, and how he keeps 'skincare nomads' coming back.  #MedicalAestheticNews #LASEROPTEK #SCULPIO #PicoSculpting #DrJaehongKim #YonseiJoeunDermatology ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11286

[KIMES 2026 Special ①] Indications Are Expanding, Global Expansion Is Accelerating — K-EBD Is Reshaping the Competitive Landscape

 We visited KIMES 2026 in person. The 41st Korea International Medical & Hospital Equipment Show, held from March 19 to 22 at COEX in Seoul, drew approximately 1,490 exhibitors from 41 countries and more than 70,000 visitors. This year, the aesthetics pavilion 'BEAUTY & DERMA Seoul' expanded its floor space from the previous year, expanding the global reach of K-medical aesthetics. While AI and digital health dominated the exhibition floor, the medical aesthetics sector was telling a different story. Korean EBD companies — long established in overseas markets — are reshaping the competitive landscape not through higher power specs, but through indication expansion and global regulatory clearance. We visited the booths of six companies — LASEROPTEK, SHENB, VIOL Medical, LTRA Global, Chungwoo Medical, and Speclipse — to document this shift firsthand.  #MedicalAestheticNews #KIMES2026 #KMedicalAesthetics #LASEROPTEK #SHENB #VIOLMedical #LTRAGlobal #ChungwooMedical #Specli...

[Top Rankers] HILO WAVE — Highest Volume in the Shortest Period: Dr. Changhwan Cho, Dongan Joongsim Clinic — 'Being Able to Perform the Procedure Without Stress — That Is the Advantage'

 In aesthetic medicine, a high procedural volume for a specific product is more than a number — it reflects accumulated clinical expertise and patient trust built through consistent outcomes. The Top Rankers series spotlights the practitioners who have built those real-world track records. This edition features Dr. Changhwan Cho of Dongan Joongsim Clinic, who recorded the highest case volume for HILO WAVE in the shortest period since its launch. HILO WAVE is an HA-based biostimulator by HIGHER Corporation. A longtime researcher in anti-aging medicine, Dr. Cho made HILO WAVE his primary biostimulator for two decisive reasons: immediate reversibility via hyaluronidase, and the biological activity within the ECM enabled by its proprietary DHC (Dual Hyaluronic Acid Compound) structure. "Being able to perform the procedure without stress — that is the advantage," he emphasizes. From his criteria for choosing between the P.D.I.T. and waving cannulation protocols, to energy-based de...

[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ㉚ | Interview with Dr. Hosung Choi, KOL for P198 ExoHealer & ExoNature

 Primoris International continued its active global expansion at IMCAS World Congress 2026 in Paris, led by its P198 exosome skin booster line. We spoke with Dr. Hosung Choi (LIEUL Clinic, Seoul), who served as a speaker at the company's open lecture at the booth to share his clinical experience. P198 comprises two products: ExoHealer, based on umbilical cord blood stem cell-derived exosomes, and ExoNature, based on Panax ginseng-derived plant exosomes. Dr. Choi noted that "the more I learned, the more I realized how much exosome quality matters," explaining why he chose UCB-derived P198. His presentation drew particular attention for introducing lip rejuvenation as a novel indication, and he emphasized that "the anti-inflammatory effect is what makes exosomes truly stand out among skin boosters." He also observed that "the influence of K-Beauty is not fading — it is only getting stronger," crediting Korea's manufacturing excellence for the expansi...

[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ㉙ | Interview with Dr. Haeun Lee, KOL for Thermage FLX

 As Solta Medical continued expanding its global presence at IMCAS World Congress 2026 in Paris — showcasing its key portfolio, led by Thermage FLX — we sat down with Dr. Haeun Lee, Director of Foret Dermatology and a Solta Medical KOL, to hear about her clinical experience. Dr. Lee likened Thermage FLX to "a savings plan for your skin," noting that "the key is to stay consistent with about one session a year." Having initially started with a Korean monopolar RF device before switching to Thermage, she pointed to longevity of results as "the decisive difference" — explaining why patients return despite nearly double the cost. She also presented a case in which a patient in her mid-70s achieved a visible lifting effect with 900 shots, highlighting the potential even in older patients. On Eye Thermage, she called it "a treatment that cannot truly be replaced." As Public Relations Director of the Association of Korean Dermatologists, she added that ...